Use of lipid conjugates in the treatment of disease
CA 2397016 C · Owner: Shoseyov, David · Inventors: Krimsky, Miron; Yard, Benito Antonio; Ligumski, Moshe
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a compound according to the formula: (see formula I), wherein R1 is a linear saturated, mono-unsaturated, or poly-unsaturated alkyl chain ranging in , length from 2 to 30 carbon atoms; R2 is a linear saturated, mono-unsaturated, or poly-unsaturated alkyl chain ranging in length from 2 to 30 carbon atoms; Y is either nothing or a , spacer group ranging in length from 2 to 30 atoms wherein said spacer , comprises , -CO-alkylene-NH- -CO-alkylene-CO- or a combination thereof; X is either a physiologically , acceptable monomer, dimer or oligomer wherein X is a glycosaminoglycan; and n is a number , from 1 to 1,000.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 10, 2001 and granted March 29, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 10, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 10, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.